Evidence map›Paper›PMID 33541953›Full record

ArticleBMJ case reports2021

Hypereosinophilic syndrome with multiorgan involvement: an interdisciplinary work-up.

Kirsten I M Looman, Maarten E Nuver, Tim I M Korevaar, Samara S Guillen

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kirsten I M LoomanInternal Medicine, Franciscus Gasthuis and Vlietland, Rotterdam, South Holland, The Netherlands.ORCID http://orcid.org/0000-0002-1984-564X
Maarten E NuverInternal Medicine, Franciscus Gasthuis and Vlietland, Rotterdam, South Holland, The Netherlands.
Tim I M KorevaarInternal Medicine, Franciscus Gasthuis and Vlietland, Rotterdam, South Holland, The Netherlands.
Samara S GuillenInternal Medicine, Franciscus Gasthuis and Vlietland, Rotterdam, South Holland, The Netherlands s.guillen@franciscus.nl.
Sint Franciscus Gasthuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A previously healthy 40-year-old man was referred to our emergency department with pruritic skin lesions and dyspnoea. Laboratory investigation revealed hypereosinophilia. Further diagnostic work-up confirmed the diagnosis of idiopathic hypereosinophilic syndrome (iHES), a rare myeloproliferative disease with a heterogeneous clinical presentation. We describe a unique case with cardiac, pulmonary, hepatic and cutaneous involvement at time of presentation. This case accentuates the importance of an extensive multidisciplinary diagnostic work-up, since iHES is a condition with potential rapid progressive multiorgan failure which requires prompt analysis and treatment. In addition, this case emphasises the importance of being aware of tunnel vision, especially during the COVID-19 pandemic, which might give rise to an increased risk of missing rare diagnoses. Our patient was treated with prednisolone, after which both his clinical condition and eosinophil concentrations markedly improved.

Indexed as

AdultAnti-Inflammatory AgentsBiopsyCOVID-19Diagnosis, DifferentialDyspneaEosinophilsHumansHypereosinophilic SyndromeMalePrednisoloneSARS-CoV-2Skin DiseasesTomography, X-Ray ComputedTreatment OutcomeAnti-Inflammatory AgentsPrednisolonedermatologyimmunologypericardial diseaserespiratory medicine

Identifiers

PMID33541953
PMCPMC7868273
OpenAlexW3129170336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.